Gleevec Decreases Cancer Recurrence For Patients With Primary Gastrointestinal Stromal Tumor

Armen Hareyan's picture
Advertisement

Primary Gastrointestinal Stromal Tumor

Preliminary results from a large, randomized, placebo-controlled clinical trial for patients with primary gastrointestinal stromal tumor, a type of tumor usually found in the stomach or small intestine, showed that patients who received imatinib mesylate (Gleevec

Advertisement